I’ve said it before, but becoming gold standard for treating leg ulcers at a time when diabetes and artery disease rates are increasing will well and truly put AVH on the map. Just my opinion DYOR
Ongoing clinical trials, page-6
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.47 |
Change
-0.060(2.37%) |
Mkt cap ! $168.2M | |||
| Open | High | Low | Value | Volume |
| $2.49 | $2.51 | $2.45 | $478.8K | 192.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 999 | $2.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.51 | 348 | 1 |
View Market Depth
| Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
| AVH (ASX) Chart |